Document Detail


Controlled trial of bright light for nonseasonal major depressive disorders.
MedLine Citation:
PMID:  1737074     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Psychotropic drug-free hospitalized veterans with nonseasonal major depressive disorders or depressed forms of bipolar disorder were treated with light for 1 week. Twenty-five patients were randomly assigned to bright white light treatment (2000-3000 lux), and 26 patients were randomized to dim red light placebo control treatment. Unlike those treated with dim red light, those treated with bright white light showed declines in three measures of depression during treatment. Partial relapse appeared within 2 days. A global depression score showed a statistically significant (p = 0.02) difference favoring bright white light treatment. Two bright-light-treated patients became mildly hypomanic, but side effects were mild. Improvement was not correlated with patient expectations; indeed, patients expected somewhat greater benefit from the placebo. Patients treated in summer responded as well as those treated in winter. Baseline electroencephalogram (EEG) sleep stage data (e.g., rapid eye movement; REM latency) did not predict treatment responses. These 1-week treatment results suggest that bright light might produce benefits for patients with nonseasonal depression. Bright light should not be recommended for routine clinical application before additional assessments with longer treatment durations are done.
Authors:
D F Kripke; D J Mullaney; M R Klauber; S C Risch; J C Gillin
Related Documents :
16271314 - Seasonal affective disorder and its prevention by anticipatory treatment with bupropion...
1477194 - The relationship between onsets of depression and sudden drops in solar irradiation.
18312654 - Depression in an evolutionary context.
16429094 - High prevalence of self-reported depressive mood during the winter season among swedish...
15004324 - Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment...
22594844 - Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Biological psychiatry     Volume:  31     ISSN:  0006-3223     ISO Abbreviation:  Biol. Psychiatry     Publication Date:  1992 Jan 
Date Detail:
Created Date:  1992-03-17     Completed Date:  1992-03-17     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0213264     Medline TA:  Biol Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  119-34     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, University of California, San Diego.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Bipolar Disorder / therapy
Depressive Disorder / physiopathology,  psychology,  therapy*
Electroencephalography
Female
Humans
Male
Phototherapy*
Psychiatric Status Rating Scales
Sleep, REM / physiology
Grant Support
ID/Acronym/Agency:
MH00117/MH/NIMH NIH HHS; MH30914/MH/NIMH NIH HHS; MH38822/MH/NIMH NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fatty acid beta-oxidation in leukocytes from control subjects and medium-chain acyl-CoA dehydrogenas...
Next Document:  Noradrenergic function in panic disorder. Effects of intravenous clonidine pretreatment on lactate i...